Deep, specific next-technology sequencing has unveiled that subclonal mutations (i.e., These present in only a portion of tumor cells) might be detected for all driver genes and they are associated with quick illness progression and lousy end result.11–13 This is particularly applicable for TP53Di sini, BP77 berkomitmen untuk memberikan pengalama